CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-355563 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 18, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
10,992
Total Value
$449,792.64
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Aug 14, 2026 | Exercise/Conversion | 3,664 | $8.27 | $30,301.28 | 13,419 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Aug 14, 2026 | Sale | 3,664 | $114.49 | $419,491.36 | 9,755 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Stock option (right to buy) | Derivative | Aug 14, 2026 | Exercise/Conversion | 3,664 | $0.00 | $0.00 | 91,986 | Direct | โ | View Details |